Hoffman Michael B (CIK 1290208) reported 28 SEC Form 4 insider transactions across 1 companies over the past 18 months (most recent 2026-05-21). Recent activity: Buy ANVS (2,562 shares), Buy ANVS (18,849 shares), Buy ANVS (54,933 shares), Buy ANVS (713,800 shares), Buy ANVS (30,000 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-05-21 | Annovis Bio, Inc. (ANVS) | Director | Buy | 2,562 | $4,484 |
| 2026-05-21 | Annovis Bio, Inc. (ANVS) | Director | Buy | 18,849 | $33,928 |
| 2026-05-21 | Annovis Bio, Inc. (ANVS) | Director | Buy | 54,933 | $104,367 |
| 2026-04-03 | Annovis Bio, Inc. (ANVS) | Director | Buy | 713,800 | $1.5M |
| 2025-12-08 | Annovis Bio, Inc. (ANVS) | Director | Buy | 30,000 | $130,200 |
| 2025-12-08 | Annovis Bio, Inc. (ANVS) | Director | Buy | 15,000 | $63,600 |
| 2025-11-25 | Annovis Bio, Inc. (ANVS) | Director | Buy | 415 | $1,718 |
| 2025-11-25 | Annovis Bio, Inc. (ANVS) | Director | Buy | 9,200 | $35,420 |
| 2025-11-25 | Annovis Bio, Inc. (ANVS) | Director | Buy | 415 | $1,718 |
| 2025-11-25 | Annovis Bio, Inc. (ANVS) | Director | Buy | 28,096 | $116,598 |
| 2025-11-25 | Annovis Bio, Inc. (ANVS) | Director | Buy | 1,489 | $6,150 |
| 2025-11-25 | Annovis Bio, Inc. (ANVS) | Director | Buy | 9,200 | $35,420 |
| 2025-11-25 | Annovis Bio, Inc. (ANVS) | Director | Buy | 1,489 | $6,150 |
| 2025-11-25 | Annovis Bio, Inc. (ANVS) | Director | Buy | 28,096 | $116,598 |
| 2025-11-21 | Annovis Bio, Inc. (ANVS) | Director | Buy | 10,000 | $34,900 |
| 2025-11-21 | Annovis Bio, Inc. (ANVS) | Director | Buy | 10,000 | $35,000 |
| 2025-11-18 | Annovis Bio, Inc. (ANVS) | Director | Buy | 15,000 | $31,650 |
| 2025-11-12 | Annovis Bio, Inc. (ANVS) | Director | Buy | 975,610 | $2.0M |
| 2025-09-03 | Annovis Bio, Inc. (ANVS) | Director | Buy | 5,000 | $11,400 |
| 2025-09-03 | Annovis Bio, Inc. (ANVS) | Director | Buy | 5,000 | $11,450 |
| 2025-09-03 | Annovis Bio, Inc. (ANVS) | Director | Buy | 5,000 | $11,500 |
| 2025-08-20 | Annovis Bio, Inc. (ANVS) | Director | Buy | 6,717 | $17,464 |
| 2025-08-20 | Annovis Bio, Inc. (ANVS) | Director | Buy | 5,283 | $13,683 |
| 2025-08-20 | Annovis Bio, Inc. (ANVS) | Director | Buy | 5,545 | $14,306 |
| 2025-08-20 | Annovis Bio, Inc. (ANVS) | Director | Buy | 1,100 | $2,827 |
Source: SEC Form 4 filings · as of 2026-05-21